GURU allows everyday investors to access the high conviction investments of some of the largest, most sophisticated hedge funds in the world.
By investing alongside hedge funds, GURU seeks to benefit from their top tier research and knowledge to outperform US equity benchmarks such as the S&P 500.
Traditionally, investing with a hedge fund requires paying an ongoing 2% management fee and 20% of profits. GURU has an expense ratio of 0.75%, potentially allowing for greater cost efficiency and liquidity.
Trading Details |
Distributions |
NAV | Daily Change | |||
Market Price | Daily Change |
Fund NAV | Market Price | Index | |
---|---|---|---|
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
1.58 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 404.81 | 2,076 | 840,385.56 |
1.44 | MDGL | MADRIGAL PHARMAC | BD59BS7 | 436.11 | 1,758 | 766,681.38 |
1.43 | SNOW | SNOWFLAKE INC | BN134B7 | 233.60 | 3,266 | 762,937.60 |
1.40 | BABA | ALIBABA GRP-ADR | BP41ZD1 | 138.55 | 5,362 | 742,905.10 |
1.35 | LAD | LITHIA MOTORS INC | 2515030 | 332.67 | 2,161 | 718,899.87 |
1.35 | AER | AERCAP HOLDINGS NV | B1HHKD3 | 124.42 | 5,750 | 715,415.00 |
1.34 | APP | APPLOVIN CORP-CLASS A | BMV3LG4 | 481.73 | 1,482 | 713,923.86 |
1.32 | THC | TENET HEALTHCARE CORP | B8DMK08 | 185.35 | 3,779 | 700,437.65 |
1.32 | MLTX | MOONLAKE IMMUNOTHERAPEUTI | BNG3F86 | 58.56 | 11,954 | 700,026.24 |
1.31 | BAC | BANK OF AMERICA CORP | 2295677 | 50.42 | 13,852 | 698,417.84 |
Exposure |
ETF Characteristics |
VERSUS | BETA |
---|---|
S&P 500 | 1.07 |
NASDAQ-100 | 0.74 |
MSCI EAFE | 0.73 |
MSCI Emg. Mkts | 0.59 |
Standard Deviation | 17.70% |
Source: AltaVista Research, LLC
* The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
** The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
Return on Equity | 13.00% | |
Weighted Avg. Market Cap | 318,306 M | |
2024 | 2025 | |
Price-to-earnings | 38.81 | 25.03 |
Price-to-book value | 3.45 | 3.08 |
Source: AltaVista Research, LLC
NAV | $57.82 | Daily Change | $0.09 | 0.16% |
Market Price | $57.82 | Daily Change | $0.12 | 0.21% |
Sector | Weight (%) | |
---|---|---|
Health Care | 21.2 | |
Information Technology | 17.6 | |
Consumer Discretionary | 12.7 | |
Industrials | 12.6 | |
Financials | 11.2 | |
Utilities | 6.1 | |
Consumer Staples | 5.0 | |
Communication Services | 4.9 | |
Energy | 3.7 | |
Materials | 3.7 | |
Real Estate | 1.3 |
Source: AltaVista Research, LLC
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Fund NAV | Market Price | Index | |
---|---|---|---|
1 Year | 24.03% | 24.32% | 24.39% |
3 Years | 17.55% | 17.73% | 17.66% |
5 Years | 10.13% | 10.21% | 10.25% |
10 Years | 8.00% | 8.02% | 8.18% |
Since Inception | 11.33% | 11.34% | 11.62% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.